Sort
15,273 grants matching “antimicrobial resistance”
Development of human adaptive immunity to Staphylococcus aureus
$628,474Juliane Bubeck Wardenburg · Washington University · R01 · FY2023 · AI
Development of human adaptive immunity to Staphylococcus aureus
$628,474Juliane Bubeck Wardenburg · Washington University · R01 · FY2024 · AI
Anti-infectives that target bacterial ribosomes
$628,462Philip R Cunningham · Wayne State University · U01 · FY2006 · AI
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
$628,385Zheng W Chen · University Of Illinois At Chicago · R01 · FY2016 · OD
An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
$628,362Steven Carl George · University Of California At Davis · R01 · FY2022 · EB
SIS multicenter study of duration of antibiotics for intraabdominal infection
$628,004Robert G Sawyer · University Of Virginia · R01 · FY2009 · GM
Rational design of transferrin binding protein-based vaccines to combat gonorrhea
$627,981Cynthia Nau Cornelissen · Georgia State University · R01 · FY2021 · AI
Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
$627,727Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children
$627,726Judd L. Walson · University Of Washington · R01 · FY2015 · HD
Task 2: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria
$627,668David Beasley · University Of Texas Med Br Galveston · N01 · FY2017 · AI
Targeting the functions of the gonococcal Type IV pilus
$627,590H. Steven Seifert · Northwestern University At Chicago · R01 · FY2025 · AI
Quorum sensing, diversity and skin inflammation
$627,561Alexander R Horswill · University Of Colorado Denver · R01 · FY2020 · AI
RNA: New Antimicrobial Strategies
$627,444Adrian Ferre-D'amare · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa
$627,360Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2024 · AI
Biochemistry of Bacterial Cell Membranes
$627,358Hiroshi Nikaido · University Of California Berkeley · R01 · FY2013 · AI
A prospective trial of oral azithromycin when added to inhaled tobramycin in CF
$627,176David Paul Nichols · Seattle Children'S Hospital · R01 · FY2017 · HL
RISK FACTORS FOR DRUG RESISTANT PNEUMOCOCCAL PNEUMONIA
$627,125University Of Pennsylvania · R01 · FY2003 · AI
Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition
$626,888Jacob Matthew Allen · University Of Illinois At Urbana-Champaign · R01 · FY2024 · DK
Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitis
$626,887Arnold S Bayer · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2020 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling
$626,816George Louis Drusano · University Of Florida · R01 · FY2011 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea
$626,726Cynthia Nau Cornelissen · Georgia State University · R01 · FY2020 · AI
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria
$626,415Berthony Deslouches · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Structural determinants of activity and mechanism of cationic peptide antibiotic activity against colistin-resistant bacteria
$626,415Berthony Deslouches · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
$626,400Yvonne L Kapila · University Of California Los Angeles · R01 · FY2025 · CA
Determinants, Decision-Making and Outcomes of Antibiotic Use in Advanced Dementia
$626,281Susan L Mitchell · Hebrew Rehabilitation Center For Aged · R01 · FY2011 · AG